CompanyPrivateWatertown, MA

Remix Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

10-QNov 10Latest SEC filing

Form DJan 4$14M sold

November 2026

Passage Bio stockholders approve Remix Therapeutics merger proposals at special meeting

Nov 6PeoplePassage Bio, Inc.